Monkeypox Testing Market Developments and Opportunities Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Monkey Pox Testing Market Expected To Reach Based On Its 2026 Value?

The monkey pox testing market size has shown consistent expansion in recent years. It is anticipated to increase from $1.52 billion in 2025 to $1.59 billion in 2026, exhibiting a compound annual growth rate of 4.4%. This historical growth can be attributed to the worldwide spread during the 2022 outbreak, insufficient diagnostic capabilities, reliance on centralized laboratories, a lack of test kits, and delayed detection of cases.

The monkey pox testing market is anticipated to experience consistent expansion over the upcoming years. Projections indicate it will reach a value of $1.88 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.3%. This anticipated growth during the forecast timeframe is attributable to factors such as the broadening of molecular testing capabilities, the growing acceptance of point-of-care diagnostic methods, escalating governmental surveillance programs, an increase in research funding, and the advancement of rapid antigen technologies. Key trends emerging within this period involve the expansion of sophisticated molecular diagnostic platforms, the integration of AI-driven tools for outbreak prediction and case mapping, the proliferation of IoT-enabled remote testing infrastructures, the creation of automated high-throughput testing systems, and the greater incorporation of cloud-based laboratory data networks.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18817&type=smp

What Primary Drivers Are Shaping The Monkey Pox Testing Market?

The rising occurrence of monkeypox disease is anticipated to drive expansion in the monkey pox testing market going forward. Monkeypox, an uncommon viral condition, is caused by the monkeypox virus, a member of the orthodox virus genus related to the smallpox virus. The surge in monkeypox cases can be attributed to heightened human-to-human transmission, global travel, and diminished immunity resulting from the cessation of smallpox vaccination programs. Monkeypox testing facilitates the early identification of infected individuals, enabling prompt treatment and isolation to prevent the further spread of the disease. Furthermore, it assists in monitoring outbreaks and comprehending the virus’s transmission patterns. An illustration of this trend is seen in September 2023, when the World Health Organization (WHO), an intergovernmental body based in Switzerland, reported 1,131 new confirmed cases of mpox and five more related fatalities between 14 August 2023 and 11 September 2023. Consequently, the increasing incidence of monkey pox disease is fueling the expansion of the monkey pox testing market.

Which Segment Classifications Are Used In The Monkey Pox Testing Market Segment Analysis?

The monkey pox testing market covered in this report is segmented –

1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies

2) By Mode: Laboratory Testing, Point Of Care Testing

3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses

Subsegments:

1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR

2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits

3) By Other Technologies: Enzyme-Linked Immunosorbent Assay (ELISA), CRISPR-Based Testing, Serological Tests (Antibody Detection)

What Trends Are Affecting The Growth Of The Monkey Pox Testing Market?

Major companies operating in the monkey pox testing market are focusing on developing advanced solutions such as lyophilised component RT PCR kits to enhance diagnostic accessibility and reliability. Lyophilised component technology involves freeze drying the reagents so they remain stable at ambient temperatures and can be shipped without cold chain logistics. This reduces dependency on cold storage and enables deployment in remote areas while maintaining test accuracy and reliability. For instance, in August 2024, Andhra Pradesh MedTech Zone (AMTZ), an India based facility, in partnership with Transasia Diagnostics, launched the ErbaMDx Monkeypox RT-PCR Kit featuring lyophilised reagents and receiving validation from Indian Council for Medical Research (ICMR) and emergency authorization from Central Drugs Standard Control Organisation (CDSCO). The kit offers a 12 month shelf life and zero cross reactivity with other orthopoxviruses enabling highly specific detection. It allows storage and transport at ambient temperature making it suitable for remote and resource limited settings. The kit helps strengthen India’s epidemic preparedness by offering precise, reliable and accessible mpox diagnosis even in areas without cold chain infrastructure.

Which Firms Are Contributing To The Monkey Pox Testing Market Ecosystem?

Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.

Get The Full Monkey Pox Testing Market Report:

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Which Region Accounts For The Largest Portion Of The Monkey Pox Testing Market?

North America was the largest region in the monkey pox testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Monkey Pox Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Browse Through More Reports Similar to the Global Monkey Pox Testing Market 2026, By The Business Research Company

Zoonotic Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Eubiotics Market Report

https://www.thebusinessresearchcompany.com/report/eubiotics-global-market-report

Clean Label Mold Inhibitors Market Report

https://www.thebusinessresearchcompany.com/report/clean-label-mold-inhibitors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795